# Sodium Polystyrene Sulfonate

NDC: 35573-108
Generic name: sodium polystyrene sulfonate
Labeler / Manufacturer: Burel Pharmaceuticals, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: SUSPENSION
Routes: ORAL, RECTAL
Marketing started: 20251218

FDA application: ANDA214912

## Active ingredients

- SODIUM POLYSTYRENE SULFONATE: 15 g/60mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"35573-108"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=35573-108
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8bbeae67-a7ff-4fa6-b21e-fb8617cd9197